Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI
Open accessThe DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Abstract
Predicting treatment response for major depressive disorder can provide a tremendous benefit for our overstretched health care system by reducing number of treatments and time to remission, thereby decreasing morbidity. The present study used neural and performance predictors during a cognitive control task to predict treatment response (% change in Hamilton Depression Rating Scale pre- to post-treatment). Forty-nine individuals diagnosed with major depressive disorder were enrolled with intent to treat in the open-label study; 36 completed treatment, had useable data, and were included in most data analyses. Participants included in the data analysis sample received treatment with escitalopram (n = 22) or duloxetine (n = 14) for 10 weeks. Functional MRI and performance during a Parametric Go/No-go test were used to predict per cent reduction in Hamilton Depression Rating Scale scores after treatment. Haemodynamic response function-based contrasts and task-related independent components analysis (subset of sample: n = 29) were predictors. Independent components analysis component beta weights and haemodynamic response function modelling activation during Commission errors in the rostral and dorsal anterior cingulate, mid-cingulate, dorsomedial prefrontal cortex, and lateral orbital frontal cortex predicted treatment response. In addition, more commission errors on the task predicted better treatment response. Together in a regression model, independent component analysis, haemodynamic response function-modelled, and performance measures predicted treatment response with 90% accuracy (compared to 74% accuracy with clinical features alone), with 84% accuracy in 5-fold, leave-one-out cross-validation. Convergence between performance markers and functional magnetic resonance imaging, including novel independent component analysis techniques, achieved high accuracy in prediction of treatment response for major depressive disorder. The strong link to a task paradigm provided by use of independent component analysis is a potential breakthrough that can inform ways in which prediction models can be integrated for use in clinical and experimental medicine studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., Norquist, G., Howland, R. H., Lebowitz, B., McGrath, P. J., et al. (2006) · American Journal of Psychiatry · doi:10.1176/appi.ajp.163.1.28 · Cited by 3,879 · cited 3×
“On average, it takes up to 8–12 weeks to evaluate the effectiveness of a given treatment for a given person (Trivedi et al., 2006).”
Estimating the error rate of a prediction rule: improvement on cross-validation
Efron, B. (1983) · Journal of the American Statistical Association · doi:10.1080/01621459.1983.10477973 · Cited by 2,300 · cited 1×
“An analogous strategy is to perform repetitions of the same statistical procedure after removing subsets of individuals (Efron, 1986), here bins, in five or 10 crossvalidations.”
Towards better clinical prediction models: seven steps for development and an ABCD for validation
Steyerberg, E. W., & Vergouwe, Y. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu207 · Cited by 1,928
Collins, G. S., Reitsma, J. B., Altman, D. G., & Moons, K. (2015) · BMC Medicine · doi:10.1186/s12916-014-0241-z · Cited by 1,927
Right hemispheric dominance of inhibitory control: An event-related functional MRI study
Garavan, H., Ross, T. J., & Stein, E. A. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8301 · Cited by 1,394
The Economic Burden of Depression in the United States: How Did It Change Between 1990 and 2000?
Greenberg, P. E., Kessler, R. C., Birnbaum, H. G., Leong, S. A., Lowe, S. W., Berglund, P. A., & Corey-Lisle, P. K. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n1211 · Cited by 1,280 · cited 1×
“Furthermore, the additive costs of untreated and ineffectively treated depression are estimated at a half a billion dollars per year (Greenberg et al., 2003).”
Mayberg, H. S. (2003) · British Medical Bulletin · doi:10.1093/bmb/65.1.193 · Cited by 1,166 · cited 1×
“However, hyperactive amygdala and hypoactive subgenual cingulate responses to threat are inconsistent predictors of treatment response (Davidson et al., 2002; Drevets, 2003; Mayberg, 2003; Fu et al., 2004, 2013; Victor et al., 2010).”
Depression: Perspectives from Affective Neuroscience
Davidson, R. J., Pizzagalli, D., Nitschke, J. B., & Putnam, K. (2002) · Annual Review of Psychology · doi:10.1146/annurev.psych.53.100901.135148 · Cited by 1,138
The cognitive control network: Integrated cortical regions with dissociable functions
Cole, M. W., & Schneider, W. (2007) · NeuroImage · doi:10.1016/j.neuroimage.2007.03.071 · Cited by 1,091
Frontocingulate Dysfunction in Depression: Toward Biomarkers of Treatment Response
Pizzagalli, D. A. (2011) · Neuropsychopharmacology · doi:10.1038/npp.2010.166 · Cited by 945
Cited by
The promise of machine learning in predicting treatment outcomes in psychiatry
Chekroud, A. M., Bondar, J., Delgadillo, J., Doherty, G., Wasil, A., Fokkema, M., Cohen, Z., Belgrave, D., DeRubeis, R., Iniesta, R., et al. (2021) · World Psychiatry · doi:10.1002/wps.20882 · Cited by 531
Intrinsic Brain Network Biomarkers of Antidepressant Response: a Review
Dunlop, K., Talishinsky, A., & Liston, C. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1072-6 · Cited by 80
MRI predictors of pharmacotherapy response in major depressive disorder
Gerlach, A. R., Karim, H. T., Peciña, M., Ajilore, O., Taylor, W. D., Butters, M. A., & Andreescu, C. (2022) · NeuroImage: Clinical · doi:10.1016/j.nicl.2022.103157 · Cited by 57
Langenecker, S. A., Jenkins, L. M., Stange, J. P., Chang, Y.-S., DelDonno, S. R., Bessette, K. L., Passarotti, A. M., Bhaumik, R., Ajilore, O., & Jacobs, R. H. (2018) · NeuroImage: Clinical · doi:10.1016/j.nicl.2018.10.004 · Cited by 47
“Cognitive control functioning, across a number of studies, is related to degree of response to treatments for depression, and even for ability to sustain wellness (53-58).”
Self-citationCognitive Control as a 5-HT1A-Based Domain That Is Disrupted in Major Depressive Disorder
Langenecker, S. A., Mickey, B. J., Eichhammer, P., Sen, S., Elverman, K. H., Kennedy, S. E., Heitzeg, M. M., Ribeiro, S. M., Love, T. M., Hsu, D. T., et al. (2019) · Frontiers in Psychology · doi:10.3389/fpsyg.2019.00691 · Cited by 18
Self-citation
Metadata
- Authors
- Crane, N. A., Jenkins, L. M., Bhaumik, R., Dion, C., Gowins, J. R., Mickey, B. J., Zubieta, J.-K., & Langenecker, S. A.
- Venue
- Brain
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-01-24
- Volume
- 140
- Issue
- 2
- Pages
- 472-486
- ISSN
- 0006-8950 (ISSN-L)
- 1460-2156
- OpenAlex
- W2582718551
- Cited by
- 71
- References
- 32
- FWCI
- 5.89
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI. https://app.cochat.ai/papers/10.1093/brain/aww326
- The paper
- Crane, N. A., Jenkins, L. M., Bhaumik, R., Dion, C., Gowins, J. R., Mickey, B. J., Zubieta, J.-K., & Langenecker, S. A. (2017). Multidimensional prediction of treatment response to antidepressants with cognitive control and functional MRI. Brain. https://doi.org/10.1093/brain/aww326
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.